Patent intelligence · US
US 11219631
Foamable compositions, breakable foams and their uses
Foamable compositions, breakable foams and their uses
Patent details — US 11219631
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 11, 2022
- Expiration
- Jan 6, 2042
- Applicant
- Vyne Pharmaceuticals Inc.
- Claims
- 37
- CPC classes
- A61K, A61K31/196, A61K31/327, A61K31/573
Quick answer
US 11219631 (Foamable compositions, breakable foams and their uses) is held by Vyne Pharmaceuticals Inc.. Status: granted. Granted Jan 11, 2022. Expires Jan 6, 2042 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Vyne Pharmaceuticals Inc.
- Grant date
- Expiration
- Claims
- 37
- CPC classes
- A61K, A61K31/196, A61K31/327, A61K31/573, A61K31/58, A61K31/7056
More from Vyne Pharmaceuticals Inc.
Related pharmaceutical patents in our USPTO index.
-
US 11433025
Oil foamable carriers and formulations
granted -
US 11103454
Wax foamable vehicle and pharmaceutical compositions thereof
granted -
US 11033491
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
granted -
US 11026920
Use of NK-1 receptor antagonist serlopitant in pruritus
granted -
US 10967063
Surfactant-free, water-free formable composition and breakable foams and their uses
granted -
US 10946101
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
granted
Frequently asked questions
What is US patent 11219631?
US 11219631 (Foamable compositions, breakable foams and their uses) is held by Vyne Pharmaceuticals Inc.. Status: granted. Granted Jan 11, 2022. Expires Jan 6, 2042 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11219631?
Vyne Pharmaceuticals Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 7 pharmaceutical patents for this assignee.
When does US 11219631 expire?
Our index shows an expiration date of Jan 6, 2042 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.